<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Endogenous generation of nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi> (NO) plays an important role in the regulation of cardiovascular and <z:mp ids='MP_0001845'>inflammatory responses</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>This mediator is synthesized by a family of enzymes collectively known as NO synthase </plain></SENT>
<SENT sid="2" pm="."><plain>Several isoforms of this enzyme have been identified and can be grouped as constitutive or inducible </plain></SENT>
<SENT sid="3" pm="."><plain>Increased production of NO is reported in several <z:e sem="disease" ids="C1290884" disease_type="Disease or Syndrome" abbrv="">inflammatory disorders</z:e>, such as <z:hpo ids='HP_0100806'>sepsis</z:hpo>, <z:hpo ids='HP_0001369'>arthritis</z:hpo>, thrombotic thrombocytopenic <z:hpo ids='HP_0000979'>purpura</z:hpo> (<z:chebi fb="1" ids="18284">TTP</z:chebi>), and <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>In addition, NO upregulates cyclo-oxygenase-2 and synthesis of several other inflammatory cytokines </plain></SENT>
<SENT sid="5" pm="."><plain><z:mp ids='MP_0001845'>Inflammation</z:mp> and thrombotic complications are usually associated with <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>Earlier reports indicate the upregulation of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> <z:mp ids='MP_0001651'>necrosis</z:mp> factor-alpha (TNF-alpha), C-reactive protein (CRP), and tissue factor (TF) in patients with <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>To determine the relationship between inflammatory cytokines and NO in <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> patients with <z:e sem="disease" ids="C0398623" disease_type="Disease or Syndrome" abbrv="">hypercoagulable states</z:e>, baseline plasma samples from 160 patients with confirmed <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e> and <z:e sem="disease" ids="C0398623" disease_type="Disease or Syndrome" abbrv="">hypercoagulable state</z:e> were analyzed for NO levels </plain></SENT>
<SENT sid="8" pm="."><plain>A chemical method based on a chemiluminescent reaction between NO and ozone using a highly sensitive gas phase NO analyzer was used </plain></SENT>
<SENT sid="9" pm="."><plain>CRP, TF, and TNF-alpha were measured using enzyme-linked immunosorbent assay methods </plain></SENT>
<SENT sid="10" pm="."><plain>Of the 160 patients who were plasma tested, the baseline NO levels ranged from 13.7 to 98.6 microM (63.1+/-15.9 microM, mean+/-SD) in contrast to age-matched control, which ranged from 9.1 to 34.6 microM (19.8+/-6.2 microM, mean+/-SD, n=138) </plain></SENT>
<SENT sid="11" pm="."><plain><z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">Cancer</z:e> patients also showed marked variations in the NO levels </plain></SENT>
<SENT sid="12" pm="."><plain>Eighteen of 60 cancer patients exhibited greater than 60 microM NO levels </plain></SENT>
<SENT sid="13" pm="."><plain>The CRP, TNF-alpha and TF were also significantly elevated </plain></SENT>
<SENT sid="14" pm="."><plain>A correlation between CRP (r(2)=0.73) and NO levels was noted in <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> patients with <z:e sem="disease" ids="C0398623" disease_type="Disease or Syndrome" abbrv="">hypercoagulable state</z:e> </plain></SENT>
<SENT sid="15" pm="."><plain>These data suggest that the pathogenesis associated with <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e>/<z:e sem="disease" ids="C0398623" disease_type="Disease or Syndrome" abbrv="">hypercoagulable state</z:e> is associated with an inflammatory component </plain></SENT>
<SENT sid="16" pm="."><plain>In addition, the observed hemodynamic changes in some of the <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> patients may be due to increased NO production </plain></SENT>
</text></document>